Literature DB >> 20001209

The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy.

Yong Lin1, Lang Bai, Wenjie Chen, Shanling Xu.   

Abstract

IMPORTANCE OF THE FIELD: Nuclear factor kappa B (NF-kappaB) is activated by a variety of cancer-promoting agents. The reciprocal activation between NF-kappaB and inflammatory cytokines makes NF-kappaB important for inflammation-associated cancer development. Both the constitutive and anticancer therapeutic-induced NF-kappaB activation blunts the anticancer activities of the therapy. Elucidating the roles of NF-kappaB in cancer facilitates developing approaches for cancer prevention and therapy. AREAS COVERED IN THIS REVIEW: By searching PubMed, we summarize the progress of studies on NF-kappaB in carcinogenesis and cancer cells' drug resistance in recent 10 years. WHAT THE READER WILL GAIN: The mechanisms by which NF-kappaB activation pathways are activated; the roles and mechanisms of NF-kappaB in cell survival and proliferation, and in carcinogenesis and cancer cells' response to therapy; recent development of NF-kappaB-modulating means and their application in cancer prevention and therapy. TAKE HOME MESSAGE: NF-kappaB is involved in cancer development, modulating NF-kappaB activation pathways has important implications in cancer prevention and therapy. Due to the complexity of NF-kappaB roles in different cancers, careful evaluation of NF-kappaB's in each cancer type is crucial in this regard. More cancer cell-specific NF-kappaB inhibiting means are desired for improving anticancer efficacy and reducing systemic toxicity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20001209      PMCID: PMC3043547          DOI: 10.1517/14728220903431069

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  100 in total

1.  Recruitment of IkappaBalpha to the hes1 promoter is associated with transcriptional repression.

Authors:  Cristina Aguilera; Ruben Hoya-Arias; Guy Haegeman; Lluís Espinosa; Anna Bigas
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-09       Impact factor: 11.205

2.  Tumor necrosis factor alpha-dependent drug resistance to purine and pyrimidine analogues in human colon tumor cells mediated through IKK.

Authors:  Ling-Chi Wang; Cindy Yen Okitsu; Ebrahim Zandi
Journal:  J Biol Chem       Date:  2004-12-17       Impact factor: 5.157

Review 3.  Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation.

Authors:  Patrick Viatour; Marie-Paule Merville; Vincent Bours; Alain Chariot
Journal:  Trends Biochem Sci       Date:  2005-01       Impact factor: 13.807

4.  Epithelial-mesenchymal transition: NF-kappaB takes center stage.

Authors:  Margit A Huber; Hartmut Beug; Thomas Wirth
Journal:  Cell Cycle       Date:  2004-12-04       Impact factor: 4.534

Review 5.  Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics - an update.

Authors:  Len Neckers; Katharine Neckers
Journal:  Expert Opin Emerg Drugs       Date:  2005-02       Impact factor: 4.191

Review 6.  NF-kappaB: tumor promoter or suppressor?

Authors:  Neil D Perkins
Journal:  Trends Cell Biol       Date:  2004-02       Impact factor: 20.808

7.  Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B.

Authors:  Kirsteen J Campbell; Sonia Rocha; Neil D Perkins
Journal:  Mol Cell       Date:  2004-03-26       Impact factor: 17.970

8.  Transfection of a dominant-negative mutant NF-kB inhibitor (IkBm) represses p53-dependent apoptosis in acute lymphoblastic leukemia cells: interaction of IkBm and p53.

Authors:  Muxiang Zhou; Lubing Gu; Ningxi Zhu; William G Woods; Harry W Findley
Journal:  Oncogene       Date:  2003-11-06       Impact factor: 9.867

9.  Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models.

Authors:  Seiji Mabuchi; Masahide Ohmichi; Yukihiro Nishio; Tadashi Hayasaka; Akiko Kimura; Tsuyoshi Ohta; Maki Saito; Jun Kawagoe; Kazuhiro Takahashi; Namiko Yada-Hashimoto; Masahiro Sakata; Teiichi Motoyama; Hirohisa Kurachi; Keiichi Tasaka; Yuji Murata
Journal:  J Biol Chem       Date:  2004-03-16       Impact factor: 5.157

10.  IkappaB kinase-independent IkappaBalpha degradation pathway: functional NF-kappaB activity and implications for cancer therapy.

Authors:  Vinay Tergaonkar; Virginie Bottero; Masahito Ikawa; Qiutang Li; Inder M Verma
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

View more
  144 in total

1.  Blocking NF-κB and Akt by Hsp90 inhibition sensitizes Smac mimetic compound 3-induced extrinsic apoptosis pathway and results in synergistic cancer cell death.

Authors:  Lang Bai; Shanling Xu; Wenshu Chen; Zi Li; Xia Wang; Hong Tang; Yong Lin
Journal:  Apoptosis       Date:  2011-01       Impact factor: 4.677

2.  Down-regulation of NF-κB transcriptional activity in HIV-associated kidney disease by BRD4 inhibition.

Authors:  Guangtao Zhang; Ruijie Liu; Yifei Zhong; Alexander N Plotnikov; Weijia Zhang; Lei Zeng; Elena Rusinova; Guillermo Gerona-Nevarro; Natasha Moshkina; Jennifer Joshua; Peter Y Chuang; Michael Ohlmeyer; John Cijiang He; Ming-Ming Zhou
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

3.  Gender-specific association of NFKBIA promoter polymorphisms with the risk of sporadic colorectal cancer.

Authors:  Shing Cheng Tan; Mohd Shafi'i Mohd Suzairi; Abdul Aziz Ahmad Aizat; Mustapha Mohd Aminudin; Mohd Shahpudin Siti Nurfatimah; Venkata Murali Krishna Bhavaraju; Biswa Mohan Biswal; Ravindran Ankathil
Journal:  Med Oncol       Date:  2013-08-31       Impact factor: 3.064

4.  Curcumin enhances the efficacy of chemotherapy by tailoring p65NFκB-p300 cross-talk in favor of p53-p300 in breast cancer.

Authors:  Gouri Sankar Sen; Suchismita Mohanty; Dewan Md Sakib Hossain; Sankar Bhattacharyya; Shuvomoy Banerjee; Juni Chakraborty; Shilpi Saha; Pallab Ray; Pushpak Bhattacharjee; Debaprasad Mandal; Arindam Bhattacharya; Samit Chattopadhyay; Tanya Das; Gaurisankar Sa
Journal:  J Biol Chem       Date:  2011-10-19       Impact factor: 5.157

Review 5.  Prostate cancer: from the pathophysiologic implications of some genetic risk factors to translation in personalized cancer treatments.

Authors:  C R Balistreri; G Candore; D Lio; G Carruba
Journal:  Cancer Gene Ther       Date:  2014-01-10       Impact factor: 5.987

6.  NFκB signaling regulates embryonic and adult neurogenesis.

Authors:  Yonggang Zhang; Wenhui Hu
Journal:  Front Biol (Beijing)       Date:  2012-08

Review 7.  Multidrug-resistant cancer cells and cancer stem cells hijack cellular systems to circumvent systemic therapies, can natural products reverse this?

Authors:  Qian Zhang; Yunjiang Feng; Derek Kennedy
Journal:  Cell Mol Life Sci       Date:  2016-09-12       Impact factor: 9.261

8.  Caspase-9b Interacts Directly with cIAP1 to Drive Agonist-Independent Activation of NF-κB and Lung Tumorigenesis.

Authors:  Ngoc T Vu; Margaret A Park; Michael D Shultz; Gamze B Bulut; Amy C Ladd; Charles E Chalfant
Journal:  Cancer Res       Date:  2016-03-29       Impact factor: 12.701

9.  The E3 ubiquitin ligase MARCH8 negatively regulates IL-1β-induced NF-κB activation by targeting the IL1RAP coreceptor for ubiquitination and degradation.

Authors:  Rui Chen; Mi Li; Yu Zhang; Qian Zhou; Hong-Bing Shu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-16       Impact factor: 11.205

Review 10.  Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements.

Authors:  Khalid S A Khabar
Journal:  Cell Mol Life Sci       Date:  2010-05-22       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.